← All organizations
Highest phase reached
Phase 2
First clinical trial
Oct 1, 2015Last known activity
Jan 12, 2021
Defunct as of Apr 8, 2022
Timeline
2010s
- Jun 1, 2015
Kaleido Biosciences— Founded
2020s
- Apr 8, 2022
Kaleido Biosciences— Defunct
Drugs by trial phase (9 distinct, 11 trials)
Phase 2 (1 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Studied for
Recent trials (20)
- NCT04486482Study directorN/AJan 12, 2021
- NCT04486482Lead sponsorN/AJan 12, 2021
- NCT04508413Study directorN/AAug 12, 2020
- NCT04508413Lead sponsorN/AAug 12, 2020
- NCT04414124Study directorN/AJun 30, 2020
- NCT04414124Lead sponsorN/AJun 30, 2020
- NCT03933410Study directorPhase 2Jun 30, 2019
- NCT03944369Lead sponsorN/AJun 30, 2019
- NCT03944369Study directorN/AJun 30, 2019
- NCT03933410Lead sponsorPhase 2Jun 30, 2019
- NCT03855956Lead sponsorN/AFeb 27, 2019
- NCT03855956Study directorN/AFeb 27, 2019
- NCT03797131Lead sponsorN/AJan 6, 2019
- NCT03797131Study directorN/AJan 6, 2019
- NCT04603378Study directorN/ASep 18, 2017
Details
- Founded
- Bedford, MA, US Jun 1, 2015
- Last known activity
- Jan 12, 2021